Nebulized hPMSC-EVs
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nebulized hPMSC-EVs, covering 2026-04-07 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Nebulized 3D-cultured Human Placental Mesenchymal Stem Cell-derived Extracellular Vesicles (hPMSC-EVs) for Idiopathic Pulmonary Fibrosis [Phase 1]